Growcott J W, Jamieson A, Tarpey A V, Topham L D
Eur J Pharmacol. 1982 Dec 17;86(1):59-64. doi: 10.1016/0014-2999(82)90396-x.
Rank order potency data for substance P (SP), physalaemin and eledoisin have been determined in a variety of assays in vitro. On the guinea-pig field stimulated vas deferens, physalaemin was approximately eight and five times more potent than eledoisin and SP respectively whereas in the rat field-stimulated vas deferens, eledoisin was approximately five times more potent than either physalaemin or SP. It would appear that the guinea-pig preparation has a preponderance of 'P'-receptor subtypes, whereas the rat preparation contains mainly 'E'-receptor subtypes. We have attempted to validate the hypothesis that there are multiple tachykinin receptors. Experiments have been performed with the guinea-pig urinary bladder in vitro, using phenoxybenzamine (20 microM, 30 min) to alkylate receptor sites and using excess eledoisin (0.2-0.4 microM, 30 min) to protect receptors selectively against the effects of this agent. Our results showed that after pretreatment with phenoxybenzamine, the responses to eledoisin were significantly attenuated. Moreover, in the presence of excess eledoisin it was found that phenoxybenzamine was unable to produce any significant reduction of the subsequent responses. This difference between the responses to eledoisin and to other agonists suggests the existence of at least two different receptor subtypes for the tachykinins.
已在多种体外试验中测定了P物质(SP)、蛙皮素和eledoisin的效价顺序数据。在豚鼠场刺激输精管上,蛙皮素的效力分别比eledoisin和SP高约8倍和5倍,而在大鼠场刺激输精管中,eledoisin的效力比蛙皮素或SP高约5倍。似乎豚鼠制剂中“P”受体亚型占优势,而大鼠制剂主要含有“E”受体亚型。我们试图验证存在多种速激肽受体这一假说。已使用苯氧苄胺(20微摩尔,30分钟)使受体位点烷基化,并使用过量的eledoisin(0.2 - 0.4微摩尔,30分钟)选择性地保护受体免受该药物的影响,对豚鼠离体膀胱进行了实验。我们的结果表明,用苯氧苄胺预处理后,对eledoisin的反应明显减弱。此外,在存在过量eledoisin的情况下,发现苯氧苄胺不能使随后的反应产生任何显著降低。对eledoisin和其他激动剂反应的这种差异表明至少存在两种不同的速激肽受体亚型。